These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8422901)

  • 1. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion.
    Vaugeois JM; Bonnet JJ; Duterte-Boucher D; Costentin J
    Eur J Pharmacol; 1993 Jan; 230(2):195-201. PubMed ID: 8422901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
    Vaugeois JM; Bonnet JJ; Costentin J
    Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK
    Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the effects of dexamphetamine on locomotion and on striatal [3H]GBR 12783 binding in vivo.
    Vaugeois JM; Bonnet JJ; Costentin J
    Eur J Pharmacol; 1990 Mar; 178(2):221-7. PubMed ID: 2328762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous dopamine differently affects N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine and cocaine binding to the dopamine uptake complex.
    Maurice T; Barbanel G; Vignon J
    Gen Pharmacol; 1993 Jan; 24(1):191-4. PubMed ID: 8482495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter.
    Rothman RB; Grieg N; Kim A; De Costa BR; Rice KC; Carroll FI; Pert A
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1135-42. PubMed ID: 1475296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
    Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by dopamine of [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP, a phencyclidine derivative) binding to the dopamine uptake complex.
    Maurice T; Barbanel G; Kamenka JM; Vignon J
    Neuropharmacology; 1991 Jun; 30(6):591-8. PubMed ID: 1681444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C; Coffey LL; Reith ME
    Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
    Desai RI; Kopajtic TA; French D; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
    Héron C; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
    Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
    Bonnet JJ; Protais P; Chagraoui A; Costentin J
    Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum.
    Chagraoui A; Bonnet JJ; Protais P; Costentin J
    Neurosci Lett; 1987 Jul; 78(2):175-9. PubMed ID: 3627558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
    Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
    J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier.
    Saadouni S; Refahi-Lyamani F; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Jul; 268(2):187-97. PubMed ID: 7957640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
    Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
    J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
    Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
    Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.